<DOC>
	<DOCNO>NCT02386527</DOCNO>
	<brief_summary>Rheumatoid arthritis ( RA ) common form inflammatory arthritis . In US , estimate many 3 million adult may suffer disease . Fortunately last year , shift strategy toward early institution disease modify drug availability new class medication greatly improve outcome expect patient . The goal treatment aim toward achieve low possible level arthritis disease activity even remission , possible early possible . Research show translates minimize joint damage enhance physical function quality life RA patient . This also require diagnosis RA make early possible , herein lie challenge , i.e . identify RA patient early course disease .</brief_summary>
	<brief_title>Consortium Early Arthritis Cohorts USA</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Patient 18 year age time referral Joint symptom &lt; 12 month 2+ swollen joint OR 1 swollen joint one following : Rheumatoid Factor &gt; 20 IU , ( + ) antiCCP antibody , morning stiffness &gt; 45 minute , respond NSAIDs , ( + ) MTP squeeze test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>